CN Patent

CN111741756A — 稳定的皮质类固醇组合物

Assigned to Charlville Pharmaceutical Co ltd · Expires 2020-10-02 · 6y expired

What this patent protects

本发明涉及包含皮质类固醇和抗氧化剂的药物组合物。本发明还涉及治疗、预防或缓解胃肠道的炎性疾病和状况的症状以及与胃肠道的炎性疾病和状况相关的炎症的方法，所述方法包括施用包含皮质类固醇和抗氧化剂的药物组合物。

USPTO Abstract

本发明涉及包含皮质类固醇和抗氧化剂的药物组合物。本发明还涉及治疗、预防或缓解胃肠道的炎性疾病和状况的症状以及与胃肠道的炎性疾病和状况相关的炎症的方法，所述方法包括施用包含皮质类固醇和抗氧化剂的药物组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN111741756A
Jurisdiction
CN
Classification
—
Expires
2020-10-02
Drug substance claim
No
Drug product claim
No
Assignee
Charlville Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.